NasdaqGS - Delayed Quote • USD
Walgreens Boots Alliance, Inc. (WBA)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:59 PM EDT
Breakdown
TTM
8/31/2023
8/31/2022
8/31/2021
8/31/2020
Total Revenue
144,597,000.00
139,081,000.00
132,703,000.00
132,509,000.00
121,982,000.00
Cost of Revenue
117,721,000.00
112,009,000.00
104,437,000.00
104,442,000.00
95,905,000.00
Gross Profit
26,875,000.00
27,072,000.00
28,265,000.00
28,067,000.00
26,078,000.00
Operating Expense
28,886,000.00
34,205,000.00
27,295,000.00
24,586,000.00
25,436,000.00
Operating Income
-2,011,000.00
-7,133,000.00
970,000.00
3,481,000.00
642,000.00
Net Non Operating Interest Income Expense
-565,000.00
-580,000.00
-400,000.00
-905,000.00
-613,000.00
Other Income Expense
-11,652,000.00
2,295,000.00
3,416,000.00
-581,000.00
418,000.00
Pretax Income
-14,229,000.00
-5,419,000.00
3,985,000.00
1,995,000.00
446,000.00
Tax Provision
-1,337,000.00
-1,858,000.00
-30,000.00
667,000.00
339,000.00
Earnings from Equity Interest Net of Tax
36,000.00
33,000.00
50,000.00
627,000.00
31,000.00
Net Income Common Stockholders
-6,037,000.00
-3,080,000.00
4,337,000.00
2,542,000.00
456,000.00
Diluted NI Available to Com Stockholders
-6,037,000.00
-3,080,000.00
4,337,000.00
2,542,000.00
456,000.00
Basic EPS
-7.00
-3.57
5.02
2.94
0.52
Diluted EPS
-7.00
-3.57
5.01
2.93
0.52
Basic Average Shares
863,050.00
863,200.00
864,400.00
864,800.00
879,400.00
Diluted Average Shares
863,050.00
863,200.00
865,900.00
866,400.00
880,300.00
Total Operating Income as Reported
-14,137,000.00
-6,882,000.00
1,387,000.00
2,342,000.00
982,000.00
Total Expenses
146,607,000.00
146,214,000.00
131,732,000.00
129,028,000.00
121,341,000.00
Net Income from Continuing & Discontinued Operation
-6,037,000.00
-3,080,000.00
4,337,000.00
2,542,000.00
456,000.00
Normalized Income
5,169,771.24
-3,080,000.00
4,337,000.00
1,985,000.00
170,000.00
Interest Expense
565,000.00
580,000.00
400,000.00
905,000.00
613,000.00
Net Interest Income
-565,000.00
-580,000.00
-400,000.00
-905,000.00
-613,000.00
EBIT
-13,664,000.00
-4,839,000.00
4,385,000.00
2,900,000.00
1,059,000.00
EBITDA
-11,232,000.00
-2,582,000.00
6,375,000.00
4,873,000.00
2,986,000.00
Reconciled Cost of Revenue
117,721,000.00
112,009,000.00
104,437,000.00
104,442,000.00
95,905,000.00
Reconciled Depreciation
2,432,000.00
2,257,000.00
1,990,000.00
1,973,000.00
1,927,000.00
Net Income from Continuing Operation Net Minority Interest
-6,037,000.00
-3,080,000.00
4,337,000.00
1,985,000.00
170,000.00
Total Unusual Items Excluding Goodwill
-12,369,000.00
--
--
--
--
Total Unusual Items
-12,369,000.00
--
--
--
--
Normalized EBITDA
1,137,000.00
-2,582,000.00
6,375,000.00
4,873,000.00
2,986,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,162,228.76
--
--
--
--
8/31/2020 - 3/17/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RADCQ Rite Aid Corporation
0.0500
-31.13%
PETS PetMed Express, Inc.
4.0200
-0.74%
HITI High Tide Inc.
2.0300
0.00%
MEDS TRxADE HEALTH, Inc.
6.31
+1.61%
BIMI BIMI Holdings Inc.
1.2300
+6.96%
PINK.PR Pilulka Lékárny a.s.
180.50
-0.55%
CJJD China Jo-Jo Drugstores, Inc.
2.8340
-0.56%
HITI.V High Tide Inc.
2.7500
-1.43%
HEWA HealthWarehouse.com, Inc.
0.1190
0.00%
LFLY Leafly Holdings, Inc.
2.0400
+4.62%